Literature DB >> 24284262

Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.

Jesper Bornø Jensen1, Kristian Gaarn du Jardin1, Dekun Song1, David Budac1, Gennady Smagin1, Connie Sanchez1, Alan Lars Pehrson2.   

Abstract

Depressed patients suffer from cognitive dysfunction, including memory deficits. Acute serotonin (5-HT) depletion impairs memory and mood in vulnerable patients. The investigational multimodal acting antidepressant vortioxetine is a 5-HT3, 5-HT7 and 5-HT1D receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist and 5-HT transporter (SERT) inhibitor that enhances memory in normal rats in novel object recognition (NOR) and conditioned fear (Mørk et al., 2013). We hypothesized that vortioxetine's 5-HT receptor mechanisms are involved in its memory effects, and therefore investigated these effects in 5-HT depleted rats. Four injections of the irreversible tryptophan hydroxylase inhibitor 4-chloro-dl-phenylalanine methyl ester hydrochloride (PCPA, 86mg/kg, s.c.) induced 5-HT depletion, as measured in hippocampal homogenate and microdialysate. The effects of acute challenge with vortioxetine or the 5-HT releaser fenfluramine on extracellular 5-HT were measured in PCPA-treated and control rats. PCPA's effects on NOR and spontaneous alternation (SA) performance were assessed along with the effects of acute treatment with 5-hydroxy-l-tryptophan (5-HTP), vortioxetine, the selective 5-HT reuptake inhibitor escitalopram, or the 5-HT norepinephrine reuptake inhibitor duloxetine. SERT occupancies were estimated by ex vivo autoradiography. PCPA depleted central 5-HT by >90% in tissue and microdialysate, and impaired NOR and SA performance. Restoring central 5-HT with 5-HTP reversed these deficits. At similar SERT occupancies (>90%) vortioxetine, but not escitalopram or duloxetine, restored memory performance. Acute fenfluramine significantly increased extracellular 5-HT in control and PCPA-treated rats, while vortioxetine did so only in control rats. Thus, vortioxetine restores 5-HT depletion impaired memory performance in rats through one or more of its receptor activities.
© 2013 Published by Elsevier B.V. and ECNP.

Entities:  

Keywords:  5-HT depletion; Cognitive impairment; Lu AA21004; Major depressive disorder; Memory; Vortioxetine

Mesh:

Substances:

Year:  2013        PMID: 24284262     DOI: 10.1016/j.euroneuro.2013.10.011

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  28 in total

Review 1.  A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

2.  Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.

Authors:  Kristian Gaarn du Jardin; Nico Liebenberg; Heidi Kaastrup Müller; Betina Elfving; Connie Sanchez; Gregers Wegener
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

Review 3.  The role of cognitive dysfunction in the symptoms and remission from depression.

Authors:  Xenia Gonda; Maurizio Pompili; Gianluca Serafini; Andre F Carvalho; Zoltan Rihmer; Peter Dome
Journal:  Ann Gen Psychiatry       Date:  2015-09-22       Impact factor: 3.455

4.  A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.

Authors:  Roger S McIntyre; Søren Lophaven; Christina K Olsen
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-30       Impact factor: 5.176

5.  Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.

Authors:  Elena Dale; Hong Zhang; Steven C Leiser; Yixin Xiao; Dunguo Lu; Charles R Yang; Niels Plath; Connie Sanchez
Journal:  J Psychopharmacol       Date:  2014-08-13       Impact factor: 4.153

6.  Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats.

Authors:  Alan L Pehrson; Todd M Hillhouse; Nasser Haddjeri; Renaud Rovera; Joseph H Porter; Arne Mørk; Gennady Smagin; Dekun Song; David Budac; Manuel Cajina; Connie Sanchez
Journal:  J Pharmacol Exp Ther       Date:  2016-07-11       Impact factor: 4.030

7.  Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice.

Authors:  Li-Xin Jiang; Geng-Di Huang; Feng Su; Huali Wang; Chen Zhang; Xin Yu
Journal:  Psychopharmacology (Berl)       Date:  2020-01-18       Impact factor: 4.530

8.  5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1/β-catenin/MMP-7 signaling pathway.

Authors:  Hua Sui; Hanchen Xu; Qing Ji; Xuan Liu; Lihong Zhou; Haiyan Song; Xiqiu Zhou; Yangxian Xu; Zhesheng Chen; Jianfeng Cai; Guang Ji; Qi Li
Journal:  Oncotarget       Date:  2015-09-22

9.  Important role of 5-hydroxytryptamine in glucocorticoid-induced insulin resistance in liver and intra-abdominal adipose tissue of rats.

Authors:  Tao Li; Keke Guo; Wei Qu; Ying Han; Shanshan Wang; Min Lin; Shanshan An; Xin Li; Shaoxin Ma; Tianying Wang; Shiya Ji; Christian Hanson; Jihua Fu
Journal:  J Diabetes Investig       Date:  2015-09-13       Impact factor: 4.232

Review 10.  Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function.

Authors:  Elena Dale; Alan L Pehrson; Theepica Jeyarajah; Yan Li; Steven C Leiser; Gennady Smagin; Christina K Olsen; Connie Sanchez
Journal:  CNS Spectr       Date:  2015-09-08       Impact factor: 3.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.